Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

1.

Light subunit of neurofilament triplet protein in the cerebrospinal fluid after subthalamic nucleus stimulation for Parkinson's disease.

Constantinescu R, Holmberg B, Rosengren L, Corneliusson O, Johnels B, Zetterberg H.

Acta Neurol Scand. 2011 Sep;124(3):206-10. doi: 10.1111/j.1600-0404.2010.01451.x. Epub 2010 Oct 29.

PMID:
21039366
[PubMed - indexed for MEDLINE]
2.

SPECT and PET analysis of subthalamic stimulation in Parkinson's disease: analysis using a manual segmentation.

Haegelen C, García-Lorenzo D, Le Jeune F, Péron J, Gibaud B, Riffaud L, Brassier G, Barillot C, Vérin M, Morandi X.

J Neurol. 2010 Mar;257(3):375-82. doi: 10.1007/s00415-009-5327-8. Epub 2009 Sep 23.

PMID:
19774437
[PubMed - indexed for MEDLINE]
3.

Subthalamic nucleus stimulation does not cause deterioration of preexisting hallucinations in Parkinson's disease patients.

Yoshida F, Miyagi Y, Kishimoto J, Morioka T, Murakami N, Hashiguchi K, Samura K, Sakae N, Yamasaki R, Kawaguchi M, Sasaki T.

Stereotact Funct Neurosurg. 2009;87(1):45-9. doi: 10.1159/000195719. Epub 2009 Jan 28.

PMID:
19174620
[PubMed - indexed for MEDLINE]
4.

Chronic stimulation of the subthalamic nucleus increases daily on-time without dyskinesia in advanced Parkinson's disease.

Portman AT, van Laar T, Staal MJ, Rutgers AW, Journee HL, Leenders KL.

Parkinsonism Relat Disord. 2006 Apr;12(3):143-8. Epub 2006 Feb 3.

PMID:
16460986
[PubMed - indexed for MEDLINE]
5.

Exhaustive, one-year follow-up of subthalamic nucleus deep brain stimulation in a large, single-center cohort of parkinsonian patients.

Tir M, Devos D, Blond S, Touzet G, Reyns N, Duhamel A, Cottencin O, Dujardin K, Cassim F, Destée A, Defebvre L, Krystkowiak P.

Neurosurgery. 2007 Aug;61(2):297-304; discussion 304-5.

PMID:
17762742
[PubMed - indexed for MEDLINE]
6.

Prognostic factors of subthalamic stimulation in Parkinson's disease: a comparative study between short- and long-term effects.

Tsai ST, Lin SH, Chou YC, Pan YH, Hung HY, Li CW, Lin SZ, Chen SY.

Stereotact Funct Neurosurg. 2009;87(4):241-8. doi: 10.1159/000225977. Epub 2009 Jun 26.

PMID:
19556833
[PubMed - indexed for MEDLINE]
7.

Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.

Spottke EA, Volkmann J, Lorenz D, Krack P, Smala AM, Sturm V, Gerstner A, Berger K, Hellwig D, Deuschl G, Freund HJ, Oertel WH, Dodel RC.

J Neurol. 2002 Jun;249(6):759-66.

PMID:
12111311
[PubMed - indexed for MEDLINE]
8.

Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.

During MJ, Kaplitt MG, Stern MB, Eidelberg D.

Hum Gene Ther. 2001 Aug 10;12(12):1589-91.

PMID:
11529246
[PubMed - indexed for MEDLINE]
9.

The effects of bilateral subthalamic nucleus deep brain stimulation (STN DBS) on cognition in Parkinson disease.

Heo JH, Lee KM, Paek SH, Kim MJ, Lee JY, Kim JY, Cho SY, Lim YH, Kim MR, Jeong SY, Jeon BS.

J Neurol Sci. 2008 Oct 15;273(1-2):19-24. doi: 10.1016/j.jns.2008.06.010. Epub 2008 Jul 21.

PMID:
18640690
[PubMed - indexed for MEDLINE]
10.

Electrode position determined by fused images of preoperative and postoperative magnetic resonance imaging and surgical outcome after subthalamic nucleus deep brain stimulation.

Paek SH, Han JH, Lee JY, Kim C, Jeon BS, Kim DG.

Neurosurgery. 2008 Nov;63(5):925-36; discussion 936-7. doi: 10.1227/01.NEU.0000334045.43940.FB.

PMID:
19005383
[PubMed - indexed for MEDLINE]
11.

Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.

Anderson VC, Burchiel KJ, Hogarth P, Favre J, Hammerstad JP.

Arch Neurol. 2005 Apr;62(4):554-60.

PMID:
15824252
[PubMed - indexed for MEDLINE]
12.

Negative impact of borderline global cognitive scores on quality of life after subthalamic nucleus stimulation in Parkinson's disease.

Witt K, Daniels C, Krack P, Volkmann J, Pinsker MO, Kloss M, Tronnier V, Schnitzler A, Wojtecki L, Bötzel K, Danek A, Hilker R, Sturm V, Kupsch A, Karner E, Deuschl G.

J Neurol Sci. 2011 Nov 15;310(1-2):261-6. doi: 10.1016/j.jns.2011.06.028. Epub 2011 Jul 5.

PMID:
21733529
[PubMed - indexed for MEDLINE]
13.

Staged bilateral deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease.

Tanei T, Kajita Y, Kaneoke Y, Takebayashi S, Nakatsubo D, Wakabayashi T.

Acta Neurochir (Wien). 2009 Jun;151(6):589-94. doi: 10.1007/s00701-009-0293-6. Epub 2009 Apr 21.

PMID:
19381434
[PubMed - indexed for MEDLINE]
14.

Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.

Funkiewiez A, Ardouin C, Krack P, Fraix V, Van Blercom N, Xie J, Moro E, Benabid AL, Pollak P.

Mov Disord. 2003 May;18(5):524-30.

PMID:
12722166
[PubMed - indexed for MEDLINE]
15.

Suicide attempts after subthalamic nucleus stimulation for Parkinson's disease.

Rodrigues AM, Rosas MJ, Gago MF, Sousa C, Fonseca R, Linhares P, Basto MA, Sousa G, Garrett C, Vaz R.

Eur Neurol. 2010;63(3):176-9. doi: 10.1159/000289097. Epub 2010 Feb 27.

PMID:
20197662
[PubMed - indexed for MEDLINE]
16.

Only physical aspects of quality of life are significantly improved by bilateral subthalamic stimulation in Parkinson's disease.

Drapier S, Raoul S, Drapier D, Leray E, Lallement F, Rivier I, Sauleau P, Lajat Y, Edan G, Vérin M.

J Neurol. 2005 May;252(5):583-8. Epub 2005 Mar 23.

PMID:
15778909
[PubMed - indexed for MEDLINE]
17.

Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.

Rodriguez-Oroz MC, Obeso JA, Lang AE, Houeto JL, Pollak P, Rehncrona S, Kulisevsky J, Albanese A, Volkmann J, Hariz MI, Quinn NP, Speelman JD, Guridi J, Zamarbide I, Gironell A, Molet J, Pascual-Sedano B, Pidoux B, Bonnet AM, Agid Y, Xie J, Benabid AL, Lozano AM, Saint-Cyr J, Romito L, Contarino MF, Scerrati M, Fraix V, Van Blercom N.

Brain. 2005 Oct;128(Pt 10):2240-9. Epub 2005 Jun 23.

PMID:
15975946
[PubMed - indexed for MEDLINE]
Free Article
18.

Mood stability during acute stimulator challenge in Parkinson's disease patients under long-term treatment with subthalamic deep brain stimulation.

Berney A, Panisset M, Sadikot AF, Ptito A, Dagher A, Fraraccio M, Savard G, Pell M, Benkelfat C.

Mov Disord. 2007 Jun 15;22(8):1093-6.

PMID:
17394245
[PubMed - indexed for MEDLINE]
19.

Disease progression continues in patients with advanced Parkinson's disease and effective subthalamic nucleus stimulation.

Hilker R, Portman AT, Voges J, Staal MJ, Burghaus L, van Laar T, Koulousakis A, Maguire RP, Pruim J, de Jong BM, Herholz K, Sturm V, Heiss WD, Leenders KL.

J Neurol Neurosurg Psychiatry. 2005 Sep;76(9):1217-21.

PMID:
16107354
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Subthalamic nucleus stimulation in Parkinson's disease: postoperative CT-MRI fusion images confirm accuracy of electrode placement using intraoperative multi-unit recording.

Shin M, Lefaucheur JP, Penholate MF, Brugières P, Gurruchaga JM, Nguyen JP.

Neurophysiol Clin. 2007 Dec;37(6):457-66. Epub 2007 Oct 11.

PMID:
18083502
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk